全球牙周病治疗市场 – 行业趋势及 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球牙周病治疗市场 – 行业趋势及 2030 年预测

  • Pharmaceutical
  • Upcoming Report
  • Jul 2023
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Periodontal Disease Treatment Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 734.80 Million
Diagram Market Size (Forecast Year)
USD 61,459.30 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Bausch Health Companies
  • Colgate
  • Palmolive Company Limited
  • Mylan N.V
  • Lyne Laboratories

>全球牙周病治疗市场,按类型(牙龈炎、慢性牙周病、侵袭性牙周病、其他)、治疗类型(非手术治疗、手术治疗)、药物(全身抗生素、局部抗生素)、给药途径(口服、注射)、最终用户(医院、牙科诊所、牙科学术和研究机构、其他)、分销渠道(医院药房、零售药房、其他)划分 - 行业趋势和预测到 2030 年。

牙周病治疗市场

牙周病治疗市场分析及规模

牙周病的严重程度可从轻微到严重不等,如果不及时治疗,可能会导致牙齿脱落。全球牙周治疗市场增长的主要因素是人们越来越意识到口腔健康的重要性、人口老龄化以及新产品和新技术的开发。牙龈疾病的非手术治疗程序包括使用抗菌产品和深度清洁口腔,这已被证明足以逆转早期牙周疾病。处方抗生素(包括外用和口服)用于控制牙龈组织的炎症和牙菌斑。口服抗生素被放置在牙龈和牙齿之间因微生物感染而形成的缝隙中,通常称为牙周袋。

预测期内,对更好口腔卫生的需求不断增长,推动全球牙周治疗市场增长。口腔卫生已成为保持健康的最重要参数之一。因此,人们对口腔卫生的认识不断提高,推动了牙周治疗市场的发展,特别是在发达国家。世界卫生组织 (WHO) 指出,超过 5.3 亿儿童患有乳牙龋齿。由于人们对更好口腔卫生的认识不断提高,全球牙周治疗市场将在预测期内迅速扩大。此外,牙周病治疗技术的进步为牙周病治疗市场参与者在 2023 年至 2030 年的预测期内带来了盈利机会。

Data Bridge Market Research 分析,牙周病治疗市场在 2022 年为 7.348 亿美元,到 2030 年将飙升至 614.593 亿美元,预计在预测期内的复合年增长率为 9.2%。这表明市场价值。由于医院的应用范围广泛,“医院”在牙周病治疗市场类型细分中占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

牙周病治疗市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2015-2020)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

按类型(牙龈炎、慢性牙周病、侵袭性牙周病等)、治疗类型(非手术治疗、手术治疗)、药物(全身抗生素、局部抗生素)、给药途径(口服、注射)、最终用户(医院、牙科诊所、牙科学术和研究机构等)、分销渠道(医院药房、零售药房等)

覆盖国家

北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。

涵盖的市场参与者

Bausch Health Companies Inc.(加拿大)、高露洁棕榄公司(印度)有限公司、Mylan NV(美国)、Lyne Laboratories(美国)、WOCKHARDT(印度)、Xttrium Laboratories(美国)、Sunstar Suisse SA(瑞士)、3M(美国)、Dexcel Pharma(以色列)、Izun Pharmaceuticals(美国)、Tolmar Pharmaceuticals, Inc(美国)、辉瑞公司(美国)、Noveome Biotherapeutics, Inc(美国)、Kaken Pharmaceutical Co.,Ltd.(日本)等

市场机会

  • 研究活动不断增加
  • 正在进行的临床试验

市场定义

牙周病是一种渐进性慢性炎症性疾病,会影响牙龈的支撑组织和周围组织以及下颌骨。如果不及时治疗,这种疾病会导致牙龈出血、溃疡、牙齿脱落和咀嚼疼痛等严重问题。它也被称为牙龈疾病或牙周炎。

全球牙周病治疗市场动态

驱动程序

  • 牙科疾病发病率不断上升

As per the estimates of the World Health Organization (WHO), severe periodontal disease, resulting in tooth loss is found in 15-20% of middle-aged adults (35-44 years). In addition, ageing population also poses a risk for dental disorders (such as dental cavities and periodontal disease), which results in complete tooth loss. For instance, according to WHO, about 30% of people aged 65-74 have no natural teeth.

  • Rising number of geriatric population

Expanding geriatric population worldwide is predicted to favour the periodontal disease treatment demand as this population is more prone to develop diseases. The number of persons above 65 years is projected to double in the coming years. The old age people are prone to various chronic diseases such as dental disorders, which can foster the demand for the periodontal disease treatment across the globe.

According to the United Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 and this number is expected 2.1 billion by 2050.

The increasing geriatric population, higher volume for digital imaging and overpowering medical needs demands for the rise in periodontal disease treatment market growth. Affordability for advanced computers with PERIODONTAL DISEASE TREATMENT aided units have seen a rise over the past few years. Manufacturers of PERIODONTAL DISEASE TREATMENT equipment helps in enhancing the imaging application, the availability of small sized scanners and scanning the patients in the upright position by flat panel detector.

  • Rise in inclination towards Periodontal disease treatment

Periodontal diseases can range from mild to severe and can cause tooth loss if left untreated. The major factors for growth of the global periodontal therapeutics market are the increasing awareness of the importance of oral health, the aging population, and the development of new products and technologies. Recently, higher emphasis has been placed on the dental expertise, which will further act as driver that will lead to the growth of the periodontal disease treatment market in the above mentioned projected timeframe.

Moreover, rise in inclination towards periodontal disease treatment because of the various benefits offered by it such as lower radiation dose to patients in most cases, reasonable alternative to CT in terms of cost and improved resolution, smaller acquisition times for the resolution needed in dentistry and detailed results accelerate the periodontal disease treatment market growth.

Opportunities

  • Rising innovations in dentistry

Furthermore, rising innovations in dentistry are pointing towards the linkage between oral disease and medical conditions such as diabetes, heart disease, rheumatoid arthritis, and certain types of cancer. Dental and medical professionals are increasingly collaborating in order to provide optimal care, especially in the cases of medically compromised patients owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, it is observed that emerging technologies are increasingly adopted throughout dentistry. By embracing these improvements, the dental industry is increasingly becoming more patient-centric and fostering greater patient trust. Furthermore, growing convenience and consistency. This will further expand the market's growth rate in the future.

Restraints/Challenges

On the other hand, high cost associated with treatment and diagnostic methods and unfavorable reimbursement scenario are the factors expected to obstruct the periodontal disease treatment market growth. Moreover, limited operating revenue opportunities for research and development of targeted therapies by various pharmaceutical industries is projected to challenge the periodontal disease treatment market in the forecast period mentioned above.

This periodontal disease treatment market  report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the periodontal disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In April 2023, Novo Nordisk collaborated with Aspect Biosystems, a company involved in bioprinting biomaterials, for the development of bioprinted tissue therapeutics for obesity and diabetes.

Periodontal Disease Treatment Market Scope

The periodontal disease treatment market is segmented on the basis of type, treatment type, drugs, route of administration, end-user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Gingivitis
  • Chronic Periodontal Disease
  • Aggressive Periodontal Disease
  • Others

Treatment Type

  • Non-Surgical Treatment
  • Scaling And Root Planning
  • Medication
  • Surgical Treatment
  • Flap Surgery
  • Bone Grafts
  • Others

Drugs

  • 系统性抗生素
  • 强力霉素
  • 甲硝唑
  • 其他的
  • 局部抗生素
  • 盐酸米诺环素
  • 洗必泰

给药途径

  • 口服
  • 注射剂

终端用户

  • 医院
  • 诊所
  • 牙科诊所
  • 牙科学术机构和研究机构
  • 其他的

分销渠道

  • 医院药房
  • 零售药店
  • 其他的

牙周病治疗市场区域分析/见解

对牙周病治疗市场进行了分析,并按国家、类型基础、治疗类型、药物、给药途径、最终用户和分销渠道提供了市场规模见解和趋势。

牙周病治疗市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。   

由于主要关键参与者的存在、当地政府不断改善口腔护理的举措以及提供知识渊博的牙科工作人员以满足该地区未满足的巨大需求,北美有望在牙周病治疗市场中占据主导地位。

由于老年人口的增加和消费者对牙齿健康的认识的提高,预计亚太地区在 2023 年至 2030 年的预测期内将以最高的增长率增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

牙周病治疗市场还为您提供了每个国家/地区资本设备医疗支出增长、牙周病治疗市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对牙周病治疗市场的影响的详细市场分析。数据适用于 2015-2020 年的历史时期。

竞争格局和牙周病治疗市场份额分析

牙周病治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

牙周病治疗市场的一些主要参与者包括:

  • Bausch Health Companies Inc.(加拿大)
  • 高露洁棕榄(印度)有限公司
  • Mylan NV(美国)
  • Lyne Laboratories(美国)
  • WOCKHARDT(印度)
  • Xttrium 实验室 (美国)
  • Sunstar Suisse SA(瑞士)
  • 3M(美国)
  • Dexcel Pharma(以色列)
  • Izun Pharmaceuticals(美国)
  • Tolmar Pharmaceuticals, Inc(美国)
  • 辉瑞公司 (美国)
  • Noveome Biotherapeutics, Inc(美国)
  • 化研制药株式会社(日本)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Type (Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Others), Treatment Type (Non-surgical Treatment, Surgical Treatment), Drugs (Systematic Antibiotics, Local Antibiotics), Route of Administration (Oral, Injectable), End-User (Hospitals, Dental Clinic, Dental Academics and Research Institutes, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) – Industry Trends and Forecast to 2030. .
The Global Periodontal Disease Treatment Market size was valued at USD 734.80 USD Million in 2022.
The Global Periodontal Disease Treatment Market is projected to grow at a CAGR of 9.2% during the forecast period of 2023 to 2030.
The major players operating in the market include Bausch Health Companies , Colgate,Palmolive Company Limited, Mylan N.V, Lyne Laboratories, WOCKHARDT, Xttrium Laboratories, Sunstar Suisse S.A, 3M, Dexcel Pharma, Izun Pharmaceuticals, Tolmar Pharmaceuticals , Pfizer , Noveome Biotherapeutics , Kaken Pharmaceutical Co.,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..